Search

Qi Chen Phones & Addresses

  • Cypress, TX
  • Katy, TX
  • Houston, TX

Professional Records

Medicine Doctors

Qi Chen Photo 1

Qi Xin Chen M.P.H.

View page
Specialties:
Internal Medicine
Radiology
Diagnostic Radiology
Qi Chen Photo 2

Qi Xin Chen

View page
Specialties:
Internal Medicine
Radiology
Diagnostic Radiology
Education:
Ross University (2000) Internal Medicine

Business Records

Name / Title
Company / Classification
Phones & Addresses
Qi Chen
Vice-President
BTIC AMERICA CORPORATION
Mfg Industrial Valves · Supplies Aluminum Cylinder and Cga Valves Regulators · Nonclassifiable Establishments
6600 Sands Pt Dr STE 121, Houston, TX 77074
(713) 779-8882
Qi Chen
Secretary, Director
SOFTWARE INTEGRATED CORPORATION
Whol Computers/Peripherals · Prepackaged Software Services · Computer Sales
27911 Norfolk Trl Ln, Katy, TX 77494
2014 Edendale Cir, Katy, TX 77450
(281) 920-1088
Qi Xian Chen
NINJA JAPANESE FOOD INC
Qi Yuan Chen
OVERLORD CW CORPORATION
Qi Chen
SPRING BROTHER TRADING, INC
Qi Ying Chen
CHEN ENTERPRISE, INC
Qi Chen
Owner
Isotonix USA
Health/Allied Services
2014 Edendale Cir, Katy, TX 77450
Qi Chen
Principal
China Wok
Eating Place
1214 W 43 St, Houston, TX 77018
(832) 203-8289

Publications

Us Patents

Carboxylic Acid Derivatives That Inhibit The Binding Of Integrins To Their Receptors

View page
US Patent:
7812038, Oct 12, 2010
Filed:
Jun 14, 2005
Appl. No.:
11/152695
Inventors:
Ronald J. Biediger - Houston TX, US
Qi Chen - Carmel IN, US
E. Radford Decker - Houston TX, US
George W. Holland - Houston TX, US
Jamal M. Kassir - Stafford TX, US
Wen Li - Pearland TX, US
Robert V. Market - Pearland TX, US
Ian L. Scott - Delanson NY, US
Chengde Wu - Pearland TX, US
Jian Li - The Woodlands TX, US
Assignee:
Encysive Pharmaceuticals, Inc. - New York NY
International Classification:
A61K 31/4412
US Classification:
514352, 514345, 514349, 546183, 546290, 546296, 546297
Abstract:
A method for the inhibition of the binding of αβintegrin to its receptors, for example VCAM-1 (vascular cell adhesion molecule-1) and fibronectin; compounds that inhibit this binding; pharmaceutically active compositions comprising such compounds; and to the use of such compounds either a above, or in formulations for the control or prevention of diseases states in which αβis involved.

Carboxylic Acid Derivatives That Inhibit The Binding Of Integrins To Their Receptors

View page
US Patent:
20040063955, Apr 1, 2004
Filed:
Oct 9, 2001
Appl. No.:
09/973142
Inventors:
Ronald Biediger - Houston TX, US
Qi Chen - Carmel IN, US
E. Decker - Houston TX, US
George Holland - Houston TX, US
Jamal Kassir - Stafford TX, US
Wen Li - Pearland TX, US
Robert Market - Pearland TX, US
Ian Scott - Delanson NY, US
Chengde Wu - Pearland TX, US
Jian Li - The Woodlands TX, US
International Classification:
C07D211/40
C07D211/56
C07D211/54
US Classification:
546/216000, 546/223000, 546/237000
Abstract:
A method for the inhibition of the binding of integrin to its receptors, for example VCAM-1 (vascular cell adhesion molecule-1) and fibronectin; compounds that inhibit this binding; pharmaceutically active compositions comprising such compounds; and to the use of such compounds either a above, or in formulations for the control or prevention of diseases states in which is involved.
Qi Chen from Cypress, TX, age ~45 Get Report